It has also been reported that the PRRC2C gene is amplified and overexpressed in approximately 30% of bladder cancers [21], although our subsequent validation experiments eliminated this gene as a common amplified and overexpressed cancer gene. This evidence concerns the gene PRRC2C and cancer.